Literature DB >> 28487909

IN VITRO ANTIMICROBIAL SCREENING OF AQUILARIA AGALLOCHA ROOTS.

Kerem Canlı1, Ali Yetgin2, Ilgaz Akata3, Ergin Murat Altuner4.   

Abstract

BACKGROUND: It was previously shown that some parts of Aquilaria agallocha, which is commonly known as oud or oodh, such as roots have been used as a traditional medical herbal in different countries. In Turkey A. agallocha is one of the ingredients while preparing famous Mesir paste, which was invented as a medicinal paste and used from the Ottoman period to now at least for 500 years. The identification the in vitro antimicrobial activity of ethanol extract of A. agallocha roots is main purpose of this analysis.
MATERIALS AND METHODS: By using 17 bacteria and 1 fungi, which include Bacillus, Candida, Enterobacter, Enterococcus, Escherichia, Klebsiella, Listeria, Pseudomonas, Salmonella and Staphylococcus genera, the activity of A. agallocha root extracts were analysed by the help of the disk diffusion method, that is one of the methods commonly used to determine antimicrobial activities.
RESULTS: As a result of the study it was observed that ethanol extracts of A. agallocha roots have a clear antimicrobial activity against nearly all microorganism used in the study, but only two bacteria namely E. coli ATCC 25922 and S. typhimurium SL 1344.
CONCLUSION: According to the disk diffusion test results it may be possible to propose that A. agallocha roots should have a medicinal uses especially against E. faecium, L. monocytogenes ATCC 7644, B. subtilis DSMZ 1971, C. albicans DSMZ 1386, S. epidermidis DSMZ 20044 and S. aureus ATCC 25923.

Entities:  

Keywords:  Aquilaria agallocha; Mesir paste; antimicrobial activity; antimicrobial screening; ethanol extract

Mesh:

Substances:

Year:  2016        PMID: 28487909      PMCID: PMC5416638          DOI: 10.21010/ajtcam.v13i5.23

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


Introduction

In several places of the world, there are increasing researches for determination of the unknown activity of medicinal plant (Abbasi et al., 2010). In consequence of the expressly enhancement in infections at developing countries, new explorations for new antimicrobial agents is required. This ingredient is largely significant for medically indigent populations due to extensive bacterial resistance to current antibiotics (Okeke et al., 2005). Natural products have an antimicrobial potential which can be comparable to modern antibiotics and this situation is investigated several decades (Altuner et al., 2010; Clardy and Walsh, 2004). Humankind without scientific knowledge discovered new treatment methods through trial and error method in the history (Karasu, 2015). Mesir paste is a traditional special mixture founded during Ottoman period about 500 years ago as a medicine, which contains different types of spices and herbs, including Crocus sativus (saffron crocus), Zingiber officinale (Ginger), Terminalia citrina (black chuglam or citrine myrobalan), Cuminum cyminum (Cumin) and Aquilaria agallocha (oud or oodh). All ingredients of Mesir paste have been used for several diseases healer in Turkish folk medicine for many centuries (Oskay et al., 2010). In addition to this, especially the synergistic antimicrobial effect thought to be the reason of Mesir paste’s healing effect. World Health Organization (WHO) has published a remarkable report in 2007 which not only mentions the microbial evolution but also the possible impact of increasing frequency in resistance against antibiotics for the next century. And these points are described as the critical problem for public health affair (Syed et al., 2010; WHO, 2007). In order to prevent spreading of antibiotic resistant infections, characterization of new antimicrobial substances is significant for intensive researches of scientists (Paudel et al., 2008; Ozkan et al., 2015). Medical plant is used for thousands of years to different diseases healer related to bacterial and fungal infections and this situation was investigated in huge number of study (Jones, 1996). Current researches represented that medicinal plants have production potential for new antibiotic drug (Cos et al., 2006). In this study, A. agallocha roots, which is one of the ingredients of Mesir paste, ethanol extract is analysed against 17 bacteria and 1 fungi with the disk diffusion method. Although Dash et al. (2008) analysed A. agallocha leaf and bark, which is aqueous and methanol extracts, with agar well method against Bacillus brevis, B. subtilis, P. aeruginosa and S. flexneri, our analyses are the first report for the activity of A. agallocha roots.

Materials and Methods

Extraction procedure

A. agallocha root samples were purchased from a local company. By using a pestle and a mortar, these samples were ground. Extraction solvent, which is ethanol (Sigma-Aldrich) was selected for receive active substances. Ground samples at room temperature were shaken in the ethanol for 3 days at 90 rpm. Whatman No. 1, which is filter paper, is used in order to extract filtration into evaporation flasks. By using rotary evaporator (Buchi R3), the filtrate was evaporated at 35°C. The residues were aggregated and it is used to prepare 385 mg.mL-1 of ethanolic extracts after evaporation.

Strains

For the analyses of A. agallocha roots, a broad collection of several Gram (-) and Gram (+) strains were chosen. These strains are Bacillus subtilis DSMZ 1971, Candida albicans DSMZ 1386, Enterobacter aerogenes ATCC 13048, Enterococcus durans, Enterococcus faecalis ATCC 29212, Enterococcus faecium, Escherichia coli ATCC 25922, Klebsiella pneumoniae, Listeria innocula, Listeria monocytogenes ATCC 7644, Pseudomonas aeruginosa DSMZ 50071, Pseudomonas fluorescence P1, Salmonella enteritidis ATCC 13075, Salmonella infantis, Salmonella kentucky, Salmonella typhimurium SL 1344, Staphylococcus aureus ATCC 25923 and Staphylococcus epidermidis DSMZ 20044.

Preparation of the strains for the test

All strains were incubated according to their requirements as it was previously mentioned by Canli at al (2015). For the inocula, physiological saline was used and to fix the number of the colonies in the solution it was compared to 0.5 McFarland (Hammer et al., 1999; Altuner et al., 2012).

Disk diffusion test (DDT)

The DDT was applied as it was mentioned in the previous studies (Andrews, 2003). Petri dishes having the same dimensions, which contain equal amount of Mueller Hinton Agar were used in order to standardize the work as described previously by several studies (Ilhan et al., 2006). Thirty and sixty microliters of A. agallocha root solutions which contain 11,550 μg and 23,100 μg of extract respectively were loaded on standard sterile cellulose disks (SD) which are regularly used in DDT (Mahasneh and El-Oqlah, 1999; Silici and Koc, 2006). Disks were kept at 40 °C for 24 h in sterile conditions to evaporate ethanol in the extracts as it was stated by Altuner et al (2012) previously. Saline suspension of microorganisms is used for inoculation on the surfaces of the plates. After application of the strains on plates, they were kept in aseptic conditions for couple of minutes before implementing the samples as described in the previous studies (Altuner et al., 2012). Results were identified in mm by the method mentioned by Altuner et al (2012).

Controls

Empty SD and ethanol were utilized as negative controls. Ethanol was loaded on SD first and then removed by evaporating as it was described in previous sections. On the other hand ciprofloxacin 5 μg is used as a positive control to discuss the results.

Statistics

In order to conduct a statistical analysis all tests were done in three parallels. All the results given were the mean values for these parallel studies. To accept the results as significant p was accepted to be lower than 0.05.

Discussion

Antimicrobial activity of A. agallocha root ethanol extracts were analysed in our study. SD were used for application of extracts, then they were used for DDT. The results for DDT were given in Table 1. Empty SD and ethanol loaded SD, which were negative controls, had no activity.
Table 1

Disk diffusion test results of 17 bacteria and 1 fungi which are sorted starting from the highest antimicrobial activity to the lowest. (Inhibition zones (IZ) in mm)

30μl60μlCiprofloxacin
E. faecium182028
L. monocytogenes ATCC 7644171920
B. subtilis DSMZ 1971151536
C. albicans DSMZ 13861515-
S. epidermidis DSMZ 20044141434
S. aureus ATCC 25923121322
E. durans9924
K. pneumonia9930
P. aeruginosa DSMZ 500719928
E. faecalis ATCC 292128919
E. aerogenes ATCC 130488830
P. fluorescens P18819
S. enteritidis ATCC 130758836
L. innocula7818
S. infantis7724
S. Kentucky-734
E. coli ATCC 25922---
S. typhimurium SL 1344--35

“-”: No inhibition

Disk diffusion test results of 17 bacteria and 1 fungi which are sorted starting from the highest antimicrobial activity to the lowest. (Inhibition zones (IZ) in mm) “-”: No inhibition Although Dash et al. (2008) studied the antibacterial properties of the leaf and bark of A. agallocha by agar well method against Bacillus brevis, B. subtilis, P. aeruginosa and S. flexneri previously, our analysis are the very first report of ethanol extracts of A. agallocha roots for its antimicrobial activity. Dash et al. (2008) identified that methanol extracts of leaf has an antimicrobial activity only against B. subtilis and methanol extracts of bark observed no activity, our study clearly show that ethanol extracts of A. agallocha roots are active against most of the strains tested in terms of its antimicrobial activity. Intensive care units (ICU) are very serious places for especially nosocomial infections (NI). S. aureus is known as one of the common pathogens causing NI especially in ICU (Richards et al., 1999). There are S. aureus strains related researchers for investigate antimicrobial activity of some plant extracts. For example, Nair and Chanda (2007) compared 10 medicinal plants antimicrobial effects on S. aureus strains, namely Anethum gravelons, Commiphora wightii, Emblica officinalis, Ficus benghalensis, Ficus racemosa, Ficus religiosa, Ficus tisela, Hibiscus cannabinus, Mentha arvensis and Mimusops elengi. In this study maximum IZ of ethanol extract was shown by E. officinalis with 9 mm. In the present study a 12 mm zone for 11,550 μg of A. agallocha roots and 13 mm zone for 23,100 μg of A. agallocha roots against S. aureus were observed. As the results for disk diffusion tests are compared it is easy to see that A. agallocha roots are active against S. aureus when compared to some other higher plants. But this result should be supported by MIC values. Gram (+) microorganisms are known to be more sensitive than Gram (-) microorganism against antibiotics (Faucher and Avril, 2002; Nikaido, 1998). K. pneumonia is another important Gram (-) strains which can be found in ICU causing extremely serious infections (Villegas and Quinn, 2004). Ates and Erdogrul (2003) analysed 26 mg Juniperus oxycedrus ethanol extract and it caused 9 mm of IZ against this strain. However, in this study a 9 mm of IZ was observed with 11,550 μg of A. agallocha roots extract. By comparing these studies, ethanol extracts of A. agallocha roots have higher antimicrobial activity against K. pneumonia than Juniperus oxycedrus, because our analysis have lower amount of substance. The pathogenicity of B. subtilis is normally very important only for immunocompromised patients (De Boer and Diderichsen, 1991; Galieni and Bigazzi, 1998). There are several different studies about anti-infective properties of several compounds from plant origin on these strains. For example, Parekh et al. (2005) used six plants, Acyranthus aspera, Calotropis gigantea, Carissa congesta, Fagonia cretica, Mangifera indica and Rauwolfia serpentine for this purpose. They observed 14 mm and 11mm of IZs in M. indica and C. congesta respectively, whereas 10 mm of IZs in A. aspera, C. gigantea, F. cretica and R. serpentina. In this study a 15 mm IZ was detected both for 11,550 μg and 23,100 μg of A. agallocha roots extract. As a result it can be concluded that A. agallocha roots may have a potential of using against B. subtilis infections. Conter et al. (2009) proposed that L. monocytogenes is a microorganism which are sensitive to the antibiotics which is generally used in human listeriosis treatment, but L. monocytogenes is slowly becoming antibiotic resistant. There are researches about effective treatment of human listeriosis which is related to antimicrobial resistance of this pathogen. Therefore antibacterial activity against L. monocytogenes is significant. Ates and Erdogrul (2003) identified that ethanol extract of Juniperus oxycedrus caused 7 mm of inhibition zone against L. monocytogenes whereas Cinnamomum cassia, Glycyrrhiza glabra, Coriandrum sativum and Pimpinella anisum observed no activity. In this work a 17 mm of IZ was found for 11,550 μg of A. agallocha roots and 19 mm IZ for 23,100 μg of A. agallocha roots. Comparing these results clearly presents that A agallocha roots are highly active against L. monocytogenes.

Conclusion

Consequently, A. agallocha roots have obviously antimicrobial activity against most of tested strains. Our study clearly presents that A. agallocha roots should have a possible medicinal uses especially against E. faecium, L. monocytogenes ATCC 7644, B. subtilis DSMZ 1971, C. albicans DSMZ 1386, S. epidermidis DSMZ 20044 and S. aureus ATCC 25923. However, further researches are needed in order to analyse the active substances and their activity mechanisms in details and also the MIC values. On the other hand while comparing the results with the previous studies, it should always kept in the mind that the results may differ due to geographical differences of the places where the plant samples were collected from.
  16 in total

Review 1.  Lessons from natural molecules.

Authors:  Jon Clardy; Christopher Walsh
Journal:  Nature       Date:  2004-12-16       Impact factor: 49.962

Review 2.  Antimicrobial resistance in developing countries. Part I: recent trends and current status.

Authors:  Iruka N Okeke; Ramanan Laxminarayan; Zulfiqar A Bhutta; Adriano G Duse; Philip Jenkins; Thomas F O'Brien; Ariel Pablos-Mendez; Keith P Klugman
Journal:  Lancet Infect Dis       Date:  2005-08       Impact factor: 25.071

Review 3.  Anti-infective potential of natural products: how to develop a stronger in vitro 'proof-of-concept'.

Authors:  Paul Cos; Arnold J Vlietinck; Dirk Vanden Berghe; Louis Maes
Journal:  J Ethnopharmacol       Date:  2006-04-18       Impact factor: 4.360

4.  BSAC standardized disc susceptibility testing method (version 6).

Authors:  J M Andrews
Journal:  J Antimicrob Chemother       Date:  2007-04-25       Impact factor: 5.790

5.  Antibacterial potential of Antarctic lichens against human pathogenic Gram-positive bacteria.

Authors:  Babita Paudel; Hari Datta Bhattarai; Jin Sung Lee; Soon Gyu Hong; Hyun Woung Shin; Joung Han Yim
Journal:  Phytother Res       Date:  2008-09       Impact factor: 5.878

6.  Herbs--useful plants. Their role in history and today.

Authors:  F A Jones
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-12       Impact factor: 2.566

7.  Determination of some chemical parameters and antimicrobial activity of traditional food: mesir paste.

Authors:  Mustafa Oskay; Tamer Karayildirim; Emriye Ay; Kadir Ay
Journal:  J Med Food       Date:  2010-10       Impact factor: 2.786

8.  Comparative study of in vitro methods to analyse the antifungal activity of propolis against yeasts isolated from patients with superficial mycoses.

Authors:  S Silici; A N Koc
Journal:  Lett Appl Microbiol       Date:  2006-09       Impact factor: 2.858

9.  Antimicrobial activity of essential oils and other plant extracts.

Authors:  K A Hammer; C F Carson; T V Riley
Journal:  J Appl Microbiol       Date:  1999-06       Impact factor: 3.772

10.  Ethnopharmacological application of medicinal plants to cure skin diseases and in folk cosmetics among the tribal communities of North-West Frontier Province, Pakistan.

Authors:  Arshad Mehmood Abbasi; M A Khan; Mushtaq Ahmad; Muhammad Zafar; Sarwat Jahan; Shahzia Sultana
Journal:  J Ethnopharmacol       Date:  2010-02-04       Impact factor: 4.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.